Next Science Limited (ASX:NXS)
0.1400
-0.0020 (-1.41%)
Jul 31, 2025, 4:10 PM AEST
Next Science Revenue
In the year 2024, Next Science had annual revenue of $22.82M USD with 2.87% growth. Next Science had revenue of $11.58M in the half year ending December 31, 2024, with 83.72% growth.
Revenue
$22.82M
Revenue Growth
+2.87%
P/S Ratio
1.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
41.70M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 22.82M | 636.94K | 2.87% |
Dec 31, 2023 | 22.18M | 10.47M | 89.36% |
Dec 31, 2022 | 11.71M | 2.77M | 30.90% |
Dec 31, 2021 | 8.95M | 5.51M | 160.03% |
Dec 31, 2020 | 3.44M | -619.83K | -15.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |